- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Metropolis Healthcare Ltd (METP)
Metropolis Healthcare Ltd stock price live, this page displays NSE METP stock exchange data. View the METP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Metropolis Healthcare Ltd real time stock price chart below.
What Is the Metropolis Healthcare Ltd Stock Price Today?
The Metropolis Healthcare Ltd stock price today is 2,188.50.
What Is the Stock Symbol for Metropolis Healthcare Ltd?
The stock symbol for Metropolis Healthcare Ltd is ""METP.""
What Stock Exchange Does Metropolis Healthcare Ltd Trade On?
Metropolis Healthcare Ltd is listed and trades on the NSE stock exchange.
Is Metropolis Healthcare Ltd a Good Stock to Buy?
Determining whether Metropolis Healthcare Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the METP quote. (ISIN: INE112L01020)
What Is the Metropolis Healthcare Ltd Stock Price Today?
The Metropolis Healthcare Ltd stock price today is 2,188.50.
What Is the Stock Symbol for Metropolis Healthcare Ltd?
The stock symbol for Metropolis Healthcare Ltd is ""METP.""
What Stock Exchange Does Metropolis Healthcare Ltd Trade On?
Metropolis Healthcare Ltd is listed and trades on the NSE stock exchange.
Is Metropolis Healthcare Ltd a Good Stock to Buy?
Determining whether Metropolis Healthcare Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the METP quote. (ISIN: INE112L01020)
2,188.50
+1.10(+0.05%)
Closed·
Fair Value
An estimate of a Metropolis Healthcare's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,147.10
2,204.00
52 wk Range
1,315.00
2,318.30
METP Scorecard
Full Analysis
Impressive gross profit margins
METP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Metropolis Healthcare's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,147.102,204.00
52 wk Range
1,315.002,318.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
METP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Metropolis Healthcare's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
2,144.53
Downside
-2.01%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Metropolis Healthcare Ltd Company Profile
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, youth, and corporates. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, a mobile app, a website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.
Compare METP to Peers and Sector
Metrics to compare | METP | Peers Peers - average of corresponding metrics from companies closely matching METP: KRSNAA, APOLLOHOSP, MAXHEALTH, VIJAYA, THYROCARE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMETPPeersSector |
|---|---|---|---|---|
P/E Ratio | 74.6x | 58.5x | −0.5x | |
PEG Ratio | 7.03 | 1.04 | 0.00 | |
Price/Book | 8.5x | 7.9x | 2.6x | |
Price / LTM Sales | 8.1x | 3.4x | 3.3x | |
Upside (Analyst Target) | 2.2% | 15.2% | 38.9% | |
Fair Value Upside | Unlock | −2.8% | 5.4% | Unlock |
Analyst Ratings
14 Buy
1 Hold
4 Sell
Ratings:
19 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2,144.53
(-2.01% Downside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
8.70 / 8.17
Revenue / Forecast
3.86B / 3.82B
People Also Watch
FAQ
What Stock Exchange Does Metropolis Healthcare Trade On?
Metropolis Healthcare is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Metropolis Healthcare?
The stock symbol for Metropolis Healthcare is "METP."
What Is the Metropolis Healthcare Market Cap?
As of today, Metropolis Healthcare market cap is 113.38B.
What Is Metropolis Healthcare's Earnings Per Share (TTM)?
The Metropolis Healthcare EPS (TTM) is 29.59.
When Is the Next Metropolis Healthcare Earnings Date?
Metropolis Healthcare will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is METP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Metropolis Healthcare Stock Split?
Metropolis Healthcare has split 0 times.
How Many Employees Does Metropolis Healthcare Have?
Metropolis Healthcare has 4823 employees.
What is the current trading status of Metropolis Healthcare (METP)?
As of 30 Aug 2025, Metropolis Healthcare (METP) is trading at a price of 2,188.50, with a previous close of 2,187.40. The stock has fluctuated within a day range of 2,147.10 to 2,204.00, while its 52-week range spans from 1,315.00 to 2,318.30.
What Is Metropolis Healthcare (METP) Price Target According to Analysts?
The average 12-month price target for Metropolis Healthcare is INR2144.52632, with a high estimate of INR2537 and a low estimate of INR1655. 14 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Buy. The stock has an -2.01% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.